TDOC - TDOC テラドック・ヘルス ()

TDOCのニュース

   Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip  2021/05/06 05:16:06 Benzinga
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ ) on Wednesday. SKLZ shares closed 9% lower at $15.48 on Wednesday and were down 1% in after-hours trading in the aftermath of the company reporting a wider quarterly loss alongside a surge in revenue. Ark owned about 12.9 million shares in Skillz divided between the ARK Innovation ETF (NYSE: ARKK ) and Ark Next Generation Internet ETF (NYSE: ARKW ) ahead of Wednesday's trade, worth about $263.98 million. The New York-based hedge fund had last week come out in support of the company amid short-seller allegations related to its revenue recognition practices and the NFL partnership. See Also: Cathie Wood Loaded Up Further On Skillz On Earnings Day The investment firm also bought 325,805 … Full story available on Benzinga.com
   Teladoc Stock Plummets Facing Analyst Price Target Cuts After Wider Than Expected Q1 Loss  2021/04/29 16:50:20 Benzinga
Teladoc Health (NYSE: TDOC ) reported a wider than expected Q1 loss of $1.31 per share which missed the analyst consensus estimate of $0.62, versus a loss of $0.40 a year ago. That steeper net loss stemmed in part from a $68 million increase in stock-based compensation expense, as well as amortization of acquired intangibles related to its Livongo and Intouch Health acquisitions that pulled its bottom line down by $37 million compared to the prior-year period. The biggest hit was due to an $87 million non-cash income tax charge that primarily reflected a valuation allowance on the stock compensation benefits linked to its purchase of Livongo. The company reported quarterly sales of $453.68 million, marginally above the analyst consensus of $451.92 million, up 151% Y/Y. The total visits increased 56% Y/Y to 3.2 million. The company’s revenue increased by 18% sequentially, with part of this growth … Full story available on Benzinga.com
   Teladoc Price Targets Cut by Analysts After Earnings - TheStreet  2021/04/29 12:44:42 The Street
Several analysts lower their share-price targets on Teladoc, the online healthcare provider.
   Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology  2021/04/20 13:29:29 Benzinga
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. The COVID-19 pandemic shifted life as we knew it prompting the adoption of technological medical approaches. Telemedicine, for example, was widely criticized before and now is one of the most useful tools for better patient management and minimizing disruption in healthcare delivery. In today’s world, only companies that can adapt to new medical needs will be able to thrive. In fact, many companies such as Teladoc Health Inc (NYSE: TDOC ), Medtronic (NYSE: MDT ), Johnson & Johnson (NYSE: JNJ ) and Abbott Laboratories (NYSE: ABT ), among others, create offers specifically in the medtech industry. They understand that the future of healthcare will keep relying heavily on these innovations. Biotricity Inc. (OTCQB: BTCY ), a company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and ​lifestyle, is also currently disrupting the market with its products.
   Teladoc Health Stock Faces 'Durable Growth Opportunity': Here's Why  2021/04/15 16:36:00 Benzinga
Teladoc Health Inc (NYSE: TDOC ) benefited from increased adoption of telehealth during the 2020 pandemic, according to Needham, and should be able to sustain this elevated growth “on the strength of its expansive platform.” The Teladoc Health Analyst: Ryan MacDonald initiated coverage of Teladoc Health with a Buy rating and a price target of $235. The Teladoc Health Thesis: While Teladoc Health’s stock trades at a premium valuation to its digital health peers, this premium … Full story available on Benzinga.com
   Teladoc Stock Plummets Facing Analyst Price Target Cuts After Wider Than Expected Q1 Loss  2021/04/29 16:50:20 Benzinga
Teladoc Health (NYSE: TDOC ) reported a wider than expected Q1 loss of $1.31 per share which missed the analyst consensus estimate of $0.62, versus a loss of $0.40 a year ago. That steeper net loss stemmed in part from a $68 million increase in stock-based compensation expense, as well as amortization of acquired intangibles related to its Livongo and Intouch Health acquisitions that pulled its bottom line down by $37 million compared to the prior-year period. The biggest hit was due to an $87 million non-cash income tax charge that primarily reflected a valuation allowance on the stock compensation benefits linked to its purchase of Livongo. The company reported quarterly sales of $453.68 million, marginally above the analyst consensus of $451.92 million, up 151% Y/Y. The total visits increased 56% Y/Y to 3.2 million. The company’s revenue increased by 18% sequentially, with part of this growth … Full story available on Benzinga.com
   Teladoc Price Targets Cut by Analysts After Earnings - TheStreet  2021/04/29 12:44:42 The Street
Several analysts lower their share-price targets on Teladoc, the online healthcare provider.
   Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology  2021/04/20 13:29:29 Benzinga
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. The COVID-19 pandemic shifted life as we knew it prompting the adoption of technological medical approaches. Telemedicine, for example, was widely criticized before and now is one of the most useful tools for better patient management and minimizing disruption in healthcare delivery. In today’s world, only companies that can adapt to new medical needs will be able to thrive. In fact, many companies such as Teladoc Health Inc (NYSE: TDOC ), Medtronic (NYSE: MDT ), Johnson & Johnson (NYSE: JNJ ) and Abbott Laboratories (NYSE: ABT ), among others, create offers specifically in the medtech industry. They understand that the future of healthcare will keep relying heavily on these innovations. Biotricity Inc. (OTCQB: BTCY ), a company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and ​lifestyle, is also currently disrupting the market with its products.
   Teladoc Health Stock Faces 'Durable Growth Opportunity': Here's Why  2021/04/15 16:36:00 Benzinga
Teladoc Health Inc (NYSE: TDOC ) benefited from increased adoption of telehealth during the 2020 pandemic, according to Needham, and should be able to sustain this elevated growth “on the strength of its expansive platform.” The Teladoc Health Analyst: Ryan MacDonald initiated coverage of Teladoc Health with a Buy rating and a price target of $235. The Teladoc Health Thesis: While Teladoc Health’s stock trades at a premium valuation to its digital health peers, this premium … Full story available on Benzinga.com
   Will Vaccine Under the Lens Aid Teladoc's (TDOC) Prospects? | Investing.com  2021/04/14 20:40:06 Investing.com
Stocks Analysis by Zacks Investment Research covering: Amazon.com Inc, AstraZeneca PLC ADR, Teladoc Inc, 1Life Healthcare Inc. Read Zacks Investment Research's latest article on Investing.com
   Where Teladoc Health Stands With Analysts  2021/04/13 14:49:14 Benzinga
Teladoc Health (NYSE: TDOC ) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 2 0 Somewhat Bullish 0 0 5 0 Indifferent 0 0 1 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 In the last 3 months, 11 analysts have offered 12-month price targets for Teladoc Health. The company has an average price target of $260.36 with a high of $300.00 and a low of $215.00. This current average has decreased by 1.67% from the previous average price target of $264.78. Analyst Ratings: What Are … Full story available on Benzinga.com
   Find Your Zen With These Relaxing Brands During Stress Awareness Month  2021/04/13 13:04:56 Benzinga
April is Stress Awareness Month, and given the unprecedented events of 2020, we could all use a bit of self-care and relaxation. There’s no getting around it – the past year has been stressful. A recent survey by American Psychological Association (APA) revealed that Americans were profoundly affected by the COVID-19 pandemic. Nearly one in five adults (19%) reported their mental health has worsened over the last year. These elevated stress levels can have a detrimental impact on physical health, with participants in the APA surveyed citing disrupted sleep patterns, eating more unhealthy foods than usual or weight changes as a consequence of the pandemic. This is unsurprising, given how the pandemic has disrupted work, education, health care, the economy, and relationships. These are some of the publicly traded companies people turn to for self-care and stress relief. With in-person therapy options limited last year, digital therapy flourished. BetterHelp, the largest online counseling and therapy services provider, experienced a sharp increase in downloads for its app, growing from 50,000 per month in January 2020 to 80,000 by April 2020.
   Teladoc Health Is a 'Powerhouse'. Analyst Says Stock's Plunge Is an Opportunity.  2021/04/08 13:13:00 Barron's
Shares are down 39.2% since late February, when management said on an earnings call it expects little membership growth this year.
   'Mad Money' Lightning Round: SunPower, Teladoc, More  2021/03/30 11:00:00 The Street
Jim Cramer is bullish on SunPower and Teladoc, and concerned about DocuSign in this 'ugly market.'
   Alibaba, Amazon, Palantir, Google, Takeda, Unity — What Cathie Wood's Ark Bought And Sold On Thursday  2021/03/26 04:59:35 Benzinga
Cathie Wood’s Ark Investment Management sends out an email every night listing the stocks that were bought or sold by the firm's ETFs that day. In recent months, the emails have known to cause certain stocks to see a spike in the after-hours session. Here’s a list of 39 stocks that the hedge fund bought and sold on Thursday. Trades For Ark Fintech Innovation ETF (NYSE: ARKF ): Opendoor Technologies Inc (NASDAQ: OPEN): Bought 468,600 shares of the online real estate company, representing about 0.25% of the ETF. Opendoor stock closed 2.35% higher at $23.04 on Thursday and were down 0.65% in the after-hours. It has a 52-week high of $39.24 and low of $10.55. Amazon.com Inc (NASDAQ: AMZN ): Sold 3,571 shares of the global e-commerce giant, representing about 0.28% of the ETF. Amazon.com stock closed 1.32% lower at $X on Thursday. It has a 52-week high of $3,552.25 and low of $1,885.78. Alibaba Group Holdings (NYSE: BABA ): Sold 51,402 shares of the ABC company, representing about 0.29% of the ETF.

calendar